Table 2.
Patient Demographic Data
CPB Patients (n = 17) | Control Subjects (n = 12) | p Value | |
---|---|---|---|
Age (months) | 19 (7.0–128.0) | 34 (13.3–115.0) | 0.49 |
Male | 10 (55.6) | 4 (33.3) | 0.23 |
NPO time (h) | 6 (3) | 7 (2) | 0.32 |
Surgical time (min) | 310 (247.5–378.0) | 242.5 (226.3–265.0) | 0.08 |
Bypass time (min) | 138.9 (59.2) | — | — |
Cross-clamp time (min) | 54.1 (44.7) | — | — |
Ventilator days (days) | 1.25 (0.0–5.0) | — | — |
Inotrope days (days) | |||
Milrinone | 2 (1.0–4.5) | — | — |
Epinephrine | 0 (0.0–1.8) | — | — |
Dopamine | 1.25 (0.5–2.3) | — | — |
Vasopressin | 0 | — | — |
Maximum vasoactive-inotropic score | 10.6 (3.6) | — | — |
PICU LOS (days) | 4 (3.0–6.3) | 1 (1–1) | <0.001 |
Hospital LOS (days) | 7(6–9) | 3 (3–4) | <0.001 |
Time to start feeds (h) | 37 (8.0–50.3) | 5.5 (4.0–8.5) | 0.001 |
Feeding type | |||
Regular diet | 7 (41.2) | 10 (83.3) | 0.035 |
Nasogastric feeds | 10 (58.8) | 2 (16.7) | 0.027 |
Feeding intolerance | 5 (27.8) | 0 (0.0) | <0.001 |
Steroids | 1 (5.8) | 3 (25.0) | 0.14 |
Antibiotics | 17 (100) | 12 (100) | |
Cefazolin | 16 (94) | 12 (100) | 0.84 |
Clindamycin | 1 (6) | 0 (0) |
Values are median (interquartile range) or n (%). Data were compared using Student’s t-test, the Mann-Whitney U test, or the chi-square test.
CBP = cardiopulmonary bypass; LOS = length of stay; NPO = nil per os; PICU = pediatric critical care unit.